Optimizing Treatment Strategies for Localized and Advanced Genitourinary Malignancies

The management of advanced kidney, bladder, and prostate cancer is rapidly evolving, and new robotic and minimally invasive surgical techniques are now available.

Presented by the nationally recognized Fox Chase Cancer Center genitourinary oncology team—comprising experts in urology, radiation therapy, and medical oncology—this program will cover the latest advancements in surgical techniques, radiation therapies, and medical treatments for both localized and advanced bladder, kidney, and prostate cancers.


Single-Port Robotic Surgery for Genitourinary Cancer

J. Ryan Mark, MD, FACS

J. Ryan Mark, MD, FACS

Associate Professor, Department of Urology, Fox Chase Cancer Center; Fox Chase – Temple Urologic Institute Provider

SABR for Oligometastatic Prostate Cancer and Localized Kidney Cancer

Jessica Wong, MD, MEng

Jessica Wong, MD, MEng

Assistant Director, Radiation Oncology Residency and Fellowship Training Program


Adjuvant Therapy in Renal Cell Carcinoma

Matthew Zibelman, MD

Matthew Zibelman, MD

Assistant Professor, Department of Hematology/Oncology

Objectives

After participating in this educational programs, learners should be able to:

  • Explain some of the newest surgical techniques for bladder, kidney, and prostate cancer
  • Explain the newest data in radiation options for localized and advanced GU malignancies
  • Describe new medical options and treatment options for advanced bladder, kidney, and prostate cancer